These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1413699)

  • 1. [The evaluation of the efficacy of repeated inoculations against influenza using inactivated vaccines].
    Avratinskiĭ IM; Stepankovskaia LD; Katuntsevskaia GP; Kiriliuk ZhI; Kalitsev VA; Iampol'skiĭ MP; Burdeniuk EI
    Lik Sprava; 1992 Mar; (3):79-81. PubMed ID: 1413699
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influenza live attenuated intra-nasal vaccines].
    Weil-Olivier C
    Arch Pediatr; 2010 Jun; 17(6):904-5. PubMed ID: 20654953
    [No Abstract]   [Full Text] [Related]  

  • 3. [Characteristics of the immune response in children multiply inoculated with an inactivated influenza vaccine].
    Rudenko LG; Vasil'eva RI; Smirnova LA; Doroshenko EM
    Vopr Virusol; 1988; 33(4):407-11. PubMed ID: 3195142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of annual booster inoculations against various influenza serotypes and the procedure for mass vaccination].
    Slepushkin AN; Schastnyĭ EI; Obrosova-Serova NP; Kobzeva OB; Tomas LP
    Vopr Virusol; 1987; 32(6):656-60. PubMed ID: 3445582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The evaluation of the epidemiological efficacy of 3-component inactivated influenza vaccines using an intranasal application method].
    Marinich IG; Iaroshevskaia IIu; Konareva AL; Lonskaia NI; Shadrin AS; Salmin LV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):76-8. PubMed ID: 8079581
    [No Abstract]   [Full Text] [Related]  

  • 6. [The prophylactic efficacy of the trivalent polymer-subunit influenza vaccine Grippol (3)].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Pavlova LI; Malinovskiĭ AA
    Voen Med Zh; 1997 Feb; 318(2):47-9. PubMed ID: 9148581
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibody functional activity in immunization with influenza vaccines].
    Naĭkhin AN; Artem'eva SA; Ermachenko TA; Vybornykh EN; Kustikova IuG; Doroshenko EV; Katorgina LG; Denisov GM; Kim TN
    Vopr Virusol; 1993; 38(5):204-7. PubMed ID: 8284916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E; Ioniţă E; Botez D; Matepciuc M; Tabra ME; Tecu C; Alexandrescu V; Munţiu A
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological effectiveness of a method for simultaneous immunization against influenza using live and inactivated vaccines].
    Orlov VA; Zhilova GP; Ignat'eva GS; Malikova EV; Efremov BV
    Vopr Virusol; 1982; 27(3):271-5. PubMed ID: 7123907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prospects for using inactivated influenza vaccines on the troops].
    Furgal SM; Degtiarev AA; Korol'kov VF
    Voen Med Zh; 1993 May; (5):35-6, 80. PubMed ID: 8356819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2014 Mar; 89(10):93-104. PubMed ID: 24707514
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 13. Influenza A (H3N2) component of recommended vaccine induces antibody to current virus.
    Zuckerman M; Oxford J; Wood J; Taylor J
    Lancet; 1990 Jan; 335(8682):179-80. PubMed ID: 1967480
    [No Abstract]   [Full Text] [Related]  

  • 14. [The immunological shifts in the blood sera of persons inoculated with influenza vaccines].
    Stepanovskaia LD; Solomko RM; Avratinskiĭ IM; Katuntsevskaia GP; Kiriliuk ZhI; Iampol'skiĭ MP; Burdeniuk EI
    Mikrobiol Zh (1978); 1992; 54(4):70-5. PubMed ID: 1406385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of the protective properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children].
    Burtseva EI; Obrosova-Serova NP; Govorkova EA; Rudenko LG; Vartanian RV; Beliaev AL; Ivanova VT; Musina MD; Cheshek SG; Zazimko LA
    Vopr Virusol; 1991; 36(5):375-7. PubMed ID: 1803767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.
    Sugaya N; Nerome K; Ishida M; Matsumoto M; Mitamura K; Nirasawa M
    JAMA; 1994 Oct; 272(14):1122-6. PubMed ID: 7933325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommended composition of influenza virus vaccines for use in the 2005-2006 influenza season.
    World Health Organization
    Wkly Epidemiol Rec; 2005 Feb; 80(8):71-5. PubMed ID: 15771207
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccines against avian influenza--a race against time.
    Poland GA
    N Engl J Med; 2006 Mar; 354(13):1411-3. PubMed ID: 16571885
    [No Abstract]   [Full Text] [Related]  

  • 19. [Postvaccinal anti-influenza immunity and its determining factors].
    Kastrikina LN; Lonskaia NI
    Vopr Virusol; 1990; 35(5):362-7. PubMed ID: 2267774
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of inactivated influenza vaccine in children.
    Wright PF
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.